Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 73–84 of 134 articles · Explore study findings
- Explore study findings
What mouse experiments found about kisspeptin-10 and blood glucose
Kisspeptin-10, or KP-10, is the ten-amino-acid signaling segment shared by longer kisspeptins and can activate the receptor KISS1R. Most human research on KP-10 measures reproductive hormones.
Kisspeptin-102 sources (2025, 2026)
- Explore study findings
Why timing mattered in a human kisspeptin-10 study
Kisspeptin-10, also called KP-10, is a ten-amino-acid fragment of the human kisspeptin precursor. It can stimulate the brain's gonadotropin-releasing hormone pathway. An August 2026 study asked whether intermittent exposure would sustain measurable pituitary hormone responses in healthy men.
Kisspeptin-102 sources (2024, 2026)
- Explore study findings
What frequent blood samples showed during continuous kisspeptin-10 exposure
Kisspeptin-10, or KP-10, is the ten-amino-acid fragment also called kisspeptin 112–121. It activates the kisspeptin receptor upstream of gonadotropin-releasing hormone. A 2026 experiment in healthy men tracked what happened to luteinizing hormone (LH) during continuous KP-10 exposure.
Kisspeptin-101 source (2026)
- Explore study findings
Could kisspeptin-10 provoke a vasopressin response?
Kisspeptin-10, or KP-10, is a ten-amino-acid peptide best studied for signaling through the kisspeptin receptor in reproductive physiology. A study published online in November 2025 tested a different question.
Kisspeptin-101 source (2025)
- Explore study findings
What a 2026 colitis study found for a modified form of KPV
KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. A 2026 study examined a chemically modified form that the authors called proKPV. It asked whether the modified material behaved differently from the unmodified peptide in animal models.
KPV1 source (2026)
- Explore study findings
What HHS's October 2026 notice says about KPV
KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An October 2026 U.S. Department of Health and Human Services policy identifies a specific acetate form of KPV in an interim policy concerning compounding.
KPV3 sources (2026)
- Explore study findings
Why Lipopeptide Names a Class Rather Than One Substance
A lipopeptide has both a peptide component and a lipid component. Lipids interact differently with water than many peptide chains do, so joining the two can influence where the material goes or how it assembles.
Lipopeptide2 sources (2026)
- Explore study findings
Why Some Lipopeptides Form Tapes and Others Form Micelles
A 2026 study compared how two defined lipopeptides formed such structures. Lucas de Mello and colleagues examined a palmitoyl pentapeptide used in cosmetic research and a related compound with changes in its charged amino acids. They compared the two in different salt forms and environments.
Lipopeptide1 source (2026)
- Explore study findings
What a Skin Immunity Study Reveals About Bacterial Lipopeptides
A chain with an attached lipid is one kind of lipopeptide, and microbes as well as laboratories can produce materials in this broad class. A 2026 study of bacterial lipopeptides asked how certain soluble materials affected a signal released by skin cells.
Lipopeptide1 source (2026)
- Explore study findings
What exercise and liraglutide changed in a weight-maintenance study
Liraglutide is a modified GLP-1 receptor agonist peptide. A 2026 analysis of the S-LiTE trial examined whether exercise, liraglutide or both changed measurements of blood vessel health after participants had already lost weight through a supervised program.
Liraglutide1 source (2026)
- Explore study findings
Why a five-week body composition study reported amounts and percentages
Liraglutide is a modified GLP-1 receptor agonist. A 2026 report from a small randomized study looked at how body composition changed during a short period, with special attention to the difference between the amount of lean tissue and its share of total body weight.
Liraglutide1 source (2026)
- Explore study findings
What a negative cell study contributed to the MGF debate
The short material commonly called the MGF peptide is a laboratory peptide based on part of an insulin-like growth factor 1 precursor. An older experiment published online in 2013 examined whether it would change the activity of muscle precursor cells.
MGF1 source (2013)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
